標(biāo)題: Titlebook: Adjuvant Therapy of Primary Breast Cancer; Hans-J?rg Senn,Aron Goldhirsch,Bruno Osterwalder Conference proceedings 1989 Springer-Verlag Be [打印本頁(yè)] 作者: 你太謙虛 時(shí)間: 2025-3-21 19:24
書目名稱Adjuvant Therapy of Primary Breast Cancer影響因子(影響力)
書目名稱Adjuvant Therapy of Primary Breast Cancer影響因子(影響力)學(xué)科排名
書目名稱Adjuvant Therapy of Primary Breast Cancer網(wǎng)絡(luò)公開度
書目名稱Adjuvant Therapy of Primary Breast Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Adjuvant Therapy of Primary Breast Cancer被引頻次
書目名稱Adjuvant Therapy of Primary Breast Cancer被引頻次學(xué)科排名
書目名稱Adjuvant Therapy of Primary Breast Cancer年度引用
書目名稱Adjuvant Therapy of Primary Breast Cancer年度引用學(xué)科排名
書目名稱Adjuvant Therapy of Primary Breast Cancer讀者反饋
書目名稱Adjuvant Therapy of Primary Breast Cancer讀者反饋學(xué)科排名
作者: FANG 時(shí)間: 2025-3-21 23:31 作者: 可轉(zhuǎn)變 時(shí)間: 2025-3-22 01:33 作者: 拋棄的貨物 時(shí)間: 2025-3-22 08:37
Inference for Location Parameter,an enormous capacity to develop variant phenotypes which display altered degrees of drug sensitivity. (Goldie and Coldman 1984; Von Hoff 1985). Evidence is accumulating that many of the mechanisms of specific drug resistance that have been identified in experimental systems are also likely to occur in clinical situations (Fojo et al. 1987).作者: 糾纏 時(shí)間: 2025-3-22 11:23
Dirichlet and Polya tree process,ses, the thinking has changed to that of a two-component disease: local on the one hand, and generalized on the other, the latter being more critical the larger the tumor size, the faster the tumor growth rate, the greater the lymph node involvement, and the less the differentiation on histological or nuclear grading.作者: Painstaking 時(shí)間: 2025-3-22 13:51 作者: Arteriography 時(shí)間: 2025-3-22 18:27 作者: Spartan 時(shí)間: 2025-3-22 22:03 作者: certitude 時(shí)間: 2025-3-23 03:42
https://doi.org/10.1007/978-3-642-83337-3adjuvant therapy; breast cancer; cancer; clinical trial; mortality; oncology; radiotherapy; Radiaton Oncolo作者: 安心地散步 時(shí)間: 2025-3-23 06:14
978-3-642-83339-7Springer-Verlag Berlin Heidelberg 1989作者: inventory 時(shí)間: 2025-3-23 11:23 作者: exercise 時(shí)間: 2025-3-23 14:33 作者: 解決 時(shí)間: 2025-3-23 18:40
Inference for Location Parameter,an enormous capacity to develop variant phenotypes which display altered degrees of drug sensitivity. (Goldie and Coldman 1984; Von Hoff 1985). Evidence is accumulating that many of the mechanisms of specific drug resistance that have been identified in experimental systems are also likely to occur 作者: 巫婆 時(shí)間: 2025-3-24 00:48
,Survival Analysis—Dirichlet Priors, determined by treating beyond lethal toxicity. This is not possible in humans, where attempts to define optimum treatment have resulted in many schedules and combinations, and attempts to avoid serious toxicity have produced many schemes to reduce doses and delay treatment. However, these schedules作者: 中古 時(shí)間: 2025-3-24 04:09
Dirichlet and Polya tree process,e alkylating agents drug resistance is generally difficult to produce experimentally, and a steep dose-response curve both in vitro and in vivo is maintained through multiple logs of cell kill (Frei et al. 1985, Frei et al., in press; Teicher et al. 1986). In contrast using nonalkylating agents, dru作者: 審問 時(shí)間: 2025-3-24 08:59
Inference for Location Parameter,ntreated surgical controls is seldom exceeded (Bonadonna et al. 1987; Nissen-Meyer et al. 1978; Lippmann and Chabner (1986). The absence of more effective drugs for breast cancer remains consistently the main problem. At the same time, it is being increasingly recognized that the scheduling and dosi作者: Myosin 時(shí)間: 2025-3-24 11:37 作者: 多嘴多舌 時(shí)間: 2025-3-24 17:51
Inference for Location Parameter,uce mortality in women with operable breast cancer (Bonadonna et al. 1985; Goldhirsch et al. 1986; UK-BCTSC/UICC/WHO 1984). It has been postulated that therapeutic efficacy is related to an increased tumor cell kill by higher doses of cytotoxic drugs (Bonadonna and Valagussa 1981) or by the selectio作者: 宴會(huì) 時(shí)間: 2025-3-24 19:53
Inference for Location Parameter,erimented with the use of the then relatively new cytotoxic agents, giving them at about the same time as primary surgery. The conclusions drawn by the various authors show that controversy is not new to this field!作者: 類似思想 時(shí)間: 2025-3-24 23:53
Dirichlet and Polya tree process,refers to the irradiation of potentially involved areas, which have been judged operatively or clinically to be free of cancer. As is the case with adjuvant systemic therapy, the indication for elective radiotherapy depends upon the probability with which a recurrence in the given area is to be expe作者: heart-murmur 時(shí)間: 2025-3-25 03:20 作者: 不斷的變動(dòng) 時(shí)間: 2025-3-25 09:58 作者: 無(wú)瑕疵 時(shí)間: 2025-3-25 12:09 作者: AMBI 時(shí)間: 2025-3-25 18:35 作者: Consequence 時(shí)間: 2025-3-25 20:53 作者: opinionated 時(shí)間: 2025-3-26 00:55 作者: GRAVE 時(shí)間: 2025-3-26 06:03 作者: FLUSH 時(shí)間: 2025-3-26 10:53 作者: 議程 時(shí)間: 2025-3-26 16:19 作者: ALIBI 時(shí)間: 2025-3-26 19:03
,Survival Analysis—Dirichlet Priors,sity may be calculated from intended drug doses (“projected dose intensity”) or from doses received after reductions and delays because of toxicity (“received dose intenstiy”) (Hryniuk and Bush 1984).作者: Latency 時(shí)間: 2025-3-26 23:32
Dirichlet and Polya tree process,subsequent course (Kurtz et al. 1988 a). The purpose of this paper is to analyze the development of breast recurrence as a function of time, as well as to study the prognosis following treatment of local failure.作者: Mundane 時(shí)間: 2025-3-27 04:28
Inference for Location Parameter,n of patients whose tumors are more responsive to a given treatment (e.g. patients with estrogen-receptor(ER)-positive tumors, who are receiving adjuvant endocrine therapy) (Ludwig Breast Cancer Study Group 1984). The use of sequential non-cross-resistant combinations also appears to enhance effectiveness (Perloff et al. 1986).作者: 催眠 時(shí)間: 2025-3-27 09:01 作者: Meditative 時(shí)間: 2025-3-27 11:09 作者: 單獨(dú) 時(shí)間: 2025-3-27 17:21 作者: 中世紀(jì) 時(shí)間: 2025-3-27 20:03
Dirichlet and Polya tree process,reasing doses through a multilog cell kill model. In this regard, the alkylating agents more closely resemble radiotherapy. The lack of cross-resistance among the alkylating agents in both in vitro and in vivo models has important implications for clinical treatment strategies (Frei et al. 1985; Frei et al., in press; Teicher et al. 1986).作者: 錫箔紙 時(shí)間: 2025-3-28 00:18 作者: Lucubrate 時(shí)間: 2025-3-28 02:41
0080-0015 in this disease, the benefits of therapy are relatively mod- est, the availability and interpretation of the data from trials be- comes an issue of primary importance. The effects of present treat- ment are in fact such that more patients relapse despite therapy than are estimated to benefit from i作者: 考博 時(shí)間: 2025-3-28 08:30 作者: fluffy 時(shí)間: 2025-3-28 11:14
Inference for Location Parameter,research. There is no question that such a development, if proven correct, will result in very significant practical alterations of the orthodox management of breast cancer. Therefore, before its full implementation, rigorous testing in clinical trials will be required.作者: nominal 時(shí)間: 2025-3-28 15:49 作者: apropos 時(shí)間: 2025-3-28 21:17 作者: giggle 時(shí)間: 2025-3-29 01:52
Dose Response for Adjuvant Chemotherapy of Breast Cancer: Experimental and Clinical Considerationstionsb?gen und Arbeitsmaterialien, neu in der 5. Auflage: komplett überarbeitet, erneuert und neu strukturiert, mit zus?tzlichen Assessments sowie einem Kapitel zur Pusher-Symptomatik...?..?..?.978-3-662-69112-0978-3-662-69113-7作者: 惰性女人 時(shí)間: 2025-3-29 05:27 作者: 浮雕寶石 時(shí)間: 2025-3-29 07:52
0080-0015 lected individually for each patient. However, considering the modest effect of treatment upon outcome, it is imperative that those who provide the data - those978-3-642-83339-7978-3-642-83337-3Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: 線 時(shí)間: 2025-3-29 13:28
The Milan Experience with Adjuvant Chemotherapy in Premenopausal Breast Cancering media, statistical and parametric phenomena, and biomedical applications. The book is relevant to studies of therapeutic ultrasound, blast waves and jet noise, nondestructive testing, parametric array louds978-3-031-58965-2978-3-031-58963-8作者: CAND 時(shí)間: 2025-3-29 16:37 作者: patriot 時(shí)間: 2025-3-29 20:02 作者: itinerary 時(shí)間: 2025-3-30 03:43
Front Matter actual solution even in the presence of noise perturbation. In addition, numerical simulations, including an application on winner-take-all (WTA) operation, are provided to further demonstrate the effectiveness and robustness of the constructed NSDTND model.作者: GEM 時(shí)間: 2025-3-30 04:40
Patterns of Treatment Failure — Implications for New Treatment Approacheserebral artery, (2) aneurysms located distal to the circle of Willis, (3) aneurysms with simple microneurosurgical options and difficult endovascular options, (4) multiple aneurysms that are accessible with a single surgical approach, (5) small aneurysms, (6) blood blister-like aneurysms, (7) giant 作者: Intractable 時(shí)間: 2025-3-30 11:59
New Information on Drug Resistance: Implications for the Adjuvant Treatment of Breast Cancer, these autoantibodies may be involved in the pathogenesis of the disease by mechanisms such as complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and modulation of receptor function. The effect of a neuronal autoantibody depends not only on the nature of 作者: jumble 時(shí)間: 2025-3-30 14:07 作者: growth-factor 時(shí)間: 2025-3-30 20:03
Randomized Perioperative Therapy in Operable Breast Cancer: The Ludwig Trial Vand diffusion models. Upon evaluating the advantages and possible threads, the discourse recognizes AI’s role as a collaborative tool rather than a competitor to human creativity, underscoring its ability, through combinational and exploratory creative capabilities, to augment and enhance the artist作者: 會(huì)犯錯(cuò)誤 時(shí)間: 2025-3-30 23:41
Is There a Role for Perioperative Adjuvant Cytotoxic Therapy in the Treatment of Early Breast Cancerr zielgerichteten Anpassung des Technology Acceptance Modells nach Mayer et al. (., S.?715) und den Erweiterungen von Lee und Kolodge (., S.?273) sowie Lewis und Marsh (., S.?37), werden die sieben Konstrukte Funktionalit?t (F), Zuverl?ssigkeit (Z), Kontrolle (K), Vertrauen (V), Risiko (R), Sicherhe作者: ornithology 時(shí)間: 2025-3-31 04:42 作者: mercenary 時(shí)間: 2025-3-31 09:05
Time Course and Prognosis of Mammary Failure Following Breast-Conserving Therapyas well as other connected disciplines. As such this book has wide appeal and will help in increasing fundamental knowledge of nitrogen-rich heterocycles to eventually allow for this knowledge to be transferred into industrial applications..978-981-97-4568-5978-981-97-4569-2作者: debouch 時(shí)間: 2025-3-31 11:41 作者: 嘴唇可修剪 時(shí)間: 2025-3-31 15:26
Factors Associated with Local Recurrence as a First Site of Failure Following the Conservative Treatent diagnostic pitfalls. Chapters include take home points for each disorder in concise and easy memorable manner. The book also provides diagnostic algorithms, novel prognostic and predictive factors, up-to-date treatment options, clinically relevant molecular signatures, and ongoing promising clin作者: 刺激 時(shí)間: 2025-3-31 17:38
Critical Review of Problems of Rational Follow-up and Salvage Therapyions. Despite its numerous benefits, challenges such as cost and access to technology still need to be addressed for broader implementation. Ethical considerations also arise, particularly in the context of incidental findings and the potential implications of the information uncovered through prena作者: Ankylo- 時(shí)間: 2025-3-31 23:37
Endocrine Effects of Adjuvant Chemotherapy in Premenopausal Women: Suggestions for the Future This is followed by a description of active coincidence methods, in which an external neutron source is used to induce fission in the item of interest. This section includes a discussion of the selection of the external source, the use of fast and thermal interrogation modes and a presentation of m作者: 虛度 時(shí)間: 2025-4-1 04:09
Adjuvant Chemo- and Endocrine Therapy Alone or in Combination in Premenopausal Patients (GABG Trial n is much simpler. In a PSD’s mixture model, this remark gives an idea for a smooth estimator of the mixing distribution which has the form of a finite mixture of natural conjugate priors of the PSD’s compound family. This smooth estimator is, in a sense, a kind of kernel estimator. Convergence resu
